Skip to content
News
Anal Cancer
Bladder Cancer
Bone Cancer
Brain Cancer
Breast Cancer
Cancer of Unknown Primary
Cervical Cancer
Colon Cancer
Esophageal Cancer
Gastric Cancer
GIST
Head & Neck Cancer
Hodgkins Lymphoma
Leukemia
Acute Leukemia
Chronic Lymphocytic Leukemia
Chronic Myeloid Leukemia
Liver Cancer
Lung Cancer
Melanoma
Mesothelioma
Multiple Myeloma
Myelodysplastic Syndrome
MPN-PV-ET-MF
Neuroblastoma
Neuroendocrine Tumors
Non Hodgkins Lymphoma
Ovarian Cancer
Pancreatic Cancer
Prostate Cancer
Renal Cancer
Rectal Cancer
Sarcoma
Skin Care
Skin Cancer
Testicular Cancer
Thyroid Cancer
Triple Negative Breast Cancer
Uterine Cancer
About Us
Advertising
News
Newly Diagnosed
Treatment & Care
Survivorship
Join the Community
Newsletter
Search
Acute Lymphoblastic Leukemia
October 8, 2024
FDA Expands Blincyto Approval in Frontline B-Cell Precursor Acute Lymphoblastic Leukemia
Dr. C H Weaver MD
March 22, 2023
Revumenib Shows Promise in Acute Leukemia
Dr. C H Weaver MD
October 29, 2022
FDA Approves Pemazyre for Myeloid/Lymphoid Neoplasms With FGFR1 Rearrangement
Dr. C H Weaver MD
March 3, 2021
Blincyto Prolongs Survival in Acute Lymphoblastic Leukemia (ALL)
Dr. C H Weaver MD
August 14, 2018
Treatment of Childhood Acute Lymphoblastic Leukemia
Dr. C H Weaver MD
August 14, 2018
Treatment of Adult Acute Lymphoblastic Leukemia
Dr. C H Weaver MD
August 22, 2017
Besponsa for B-cell Acute Lymphoblastic Leukemia
Dr. C H Weaver MD
Loading Comments...
Write a Comment...
Email (Required)
Name (Required)
Website
